Geron Corporation (FRA:GON)

Germany · Delayed Price · Currency is EUR

1.530

-0.079 (-4.91%)

Last updated: Feb 23, 2026, 8:22 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development of Therapeutic Products for Oncology	76.99M	237.00K	596.00K	1.39M	253.00K
Development of Therapeutic Products for Oncology Growth	32386.92%	-60.23%	-57.21%	450.59%	-45.00%
Total	76.99M	237.00K	596.00K	1.39M	253.00K
Total Growth	32386.92%	-60.23%	-57.21%	450.59%	-45.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	76.99M	237.00K	596.00K	1.39M	253.00K
United States Growth	32386.92%	-60.23%	-57.21%	450.59%	-45.00%
Total	76.99M	237.00K	596.00K	1.39M	253.00K
Total Growth	32386.92%	-60.23%	-57.21%	450.59%	-45.00%

Source: S&P Global Market Intelligence.